Apax-backed healthium divests its UK-based continence care organization - Clinisupplies

Adfactors PR | 07/12/2022 08:19 AM

Healthium Medtech, a global player in medical devices, announced that it has entered into a definitive agreement to sell its UK-based subsidiary, Clinisupplies to KKR, which is investing through its KKR Health Care Strategic Growth Fund II. The company will re-invest the proceeds from the transaction to strengthen its portfolio in advanced surgery, wound care, orthopaedics, and post-surgical care through organic and inorganic routes.

Based in Watford, UK, Clinisupplies was acquired by Healthium in 2016. The company has a strong portfolio of products in continence care and partners with the NHS to supply quality and cost-effective continence care products.

The move marks Healthium’s strategic decision to focus on innovation and expansion in areas that the organisation sees as its own core growth areas. Healthium will continue to remain in the UK through its surgical consumables portfolio.

Healthium Medtech has a diverse portfolio of medical devices and consumables, which includes surgical sutures, needles, a patented arthroscopy portfolio, patented wound care portfolio, hernia meshes, haemostats, ligation clips, surgical staplers and other wound closure devices. Currently, the company has eight manufacturing facilities across India, and holds 64 patents across US, Europe and India (including pending applications).

Speaking on the strategic move, Anish Bafna, CEO and MD, Healthium Medtech, said, "The divestment of Clinisupplies is a strategic decision in line with our business priorities and gives a solid impetus to our vision of facilitating precision medtech for every patient globally. We will continue to strengthen and expand our growing product portfolios in the surgical and the post-surgical space through continuous innovation, strong R&D and inorganic investments. We are proud to have helped Clinisupplies build and scale the business and we would like to thank CEO Paul Cook, CFO Samik Basu and the team for all their hard work and dedication over the last few years. I wish them every success for the future in this new exciting chapter with their new partner"

Paul Cook, CEO at Clinisupplies, further commented, “We would like to thank Anish and all of our colleagues at Healthium Medtech for their support over the last six years. Clinisupplies has become one of the UK's leading continence organisations supplying high quality products to the NHS and direct to patient homes. We are delighted that KKR have invested in Clinisupplies, we share the same ambitious growth plans for the organisation and the whole team looks forward to partnering on the next stage of our growth.

Healthium Medtech and Apax Partners were advised by RBC Capital Markets as lead financial advisor and Kirkland & Ellis, LLP as legal counsel. The transaction will close by January 2023.   

About Healthium Medtech Limited:

Healthium Medtech Limited is a global medtech company focused on products used in surgical, post-surgical and chronic care. One in five surgeries conducted globally uses a Healthium product. As of fiscal 2022, it is the largest independent Indian medical device company and the largest non-captive manufacturer of surgical needles globally. With a vision to provide access to precision medtech for every patient, the company has built extensive market access in India covering over 40,000 surgeons across 18,000 hospitals. Healthium also has significant global presence with exports to over 80 countries, including the USA, France, Germany and Brazil.

The company’s diverse portfolio includes 52,000 SKUs across advanced surgery, arthroscopy and wound care products. With a strong focus on R&D, the company has 8 high precision, integrated and scaled manufacturing facilities with global certifications and approvals like US FDA, C.E, CDSCO, TGA, ISO and CE under the stringent new EUDMR norms. Since fiscal 2018, the company has launched 30 new products including a patented portfolio of arthroscopy products. Since 2020, the company has completed 3 acquisitions to enhance market reach and expand its product portfolio.